Estrella Immunopharma, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
Business Address 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Mailing Address 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Phone (510) 318-9098
Fiscal Year End 1231
EIN 861314502
Financial Overview
FY2024
-$11.11M
Net Income
$4.17M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | January 22, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 6, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| S-1 IPO registration statement | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 4, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 3 Initial insider ownership report | October 1, 2025 | View on SEC |
Material Events
8-K Legal Issue January 13, 2026
High Impact
- The company has 45 calendar days to submit a compliance plan to Nasdaq.
- Estrella Immunopharma plans to hold its annual shareholder meeting in April 2026.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.